Skip to main content

Prebiotic- and Panthenol-Containing Multipurpose Healing Dermocosmetics Post-Cryotherapy for Actinic Keratoses: Results of a Randomized Controlled Trial.

Dermatology practical & conceptual2025-03-21PubMed
Total: 68.0Innovation: 6Impact: 6Rigor: 8Citation: 6

Summary

In a randomized, unblinded trial of 75 AK patients post-cryotherapy, adding a prebiotic/panthenol dermocosmetic to standard boric acid soaks shortened median healing time by 4.5 days (7 vs 11.5; P<0.0005), increased excellent cosmetic outcomes (50% vs 20%), and reduced the severity of local skin reactions, with no reported adverse events.

Key Findings

  • Randomized 75 adults post-cryotherapy to BA alone vs BA plus prebiotic/panthenol dermocosmetic
  • Healing time reduced by 4.5 days (median 7 vs 11.5 days; ~40% reduction; P<0.0005)
  • Higher rate of excellent cosmetic outcomes in complete responders (50% vs 20%)
  • Lower severity of local skin reactions (median 2 vs 3 at day 3; P<0.0001) and no reported adverse events

Clinical Implications

Consider prescribing a prebiotic/panthenol dermocosmetic after AK cryotherapy to reduce downtime, improve cosmesis, and mitigate local reactions; integrate into postprocedural care pathways.

Why It Matters

Pragmatic randomized data support a simple, safe adjunct that accelerates recovery and improves cosmetic outcomes after a common dermatologic procedure.

Limitations

  • Unblinded, single-center design may introduce performance and detection bias
  • Short follow-up (30 days) limits assessment of longer-term recurrence or scarring

Future Directions

Validate in multicenter, blinded trials with longer follow-up, cost-effectiveness analysis, and standardized cosmetic assessment (e.g., blinded photo-grading, 3D imaging).

Study Information

Study Type
RCT
Research Domain
Treatment
Evidence Level
I - Randomized controlled trial comparing adjunctive dermocosmetic vs standard care
Study Design
OTHER